Trial intelligence / Profile preview

Desipramine in Rett Syndrome

NCT00990691Phase 2Completed

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
Feb 2009
Primary completion
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of desipramine in Rett syndrome (RTT) (3 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Efficacy of the desipramine on the respiratory disturbations at 2 years. Started Feb 2009; status: completed.

02

Drugs

desipramine
03

Conditions

Rett syndrome (RTT)

Beyond the preview

Go deeper on NCT00990691.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00990691.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call